These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 7130789)

  • 1. [Increase of anti-tumor activity in experimentally induced tumor-bearing animals by simultaneous administration of two immunopotentiating agents].
    Kitasato M
    Nihon Gan Chiryo Gakkai Shi; 1982 Apr; 17(3):735-44. PubMed ID: 7130789
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combination therapy of radiation and immunomodulators in the treatment of MM46 tumor transplanted in C3H/He mice].
    Miyaji C; Ogawa Y; Imajo Y; Kimura S
    Nihon Gan Chiryo Gakkai Shi; 1982 Jun; 17(4):1035-42. PubMed ID: 7130793
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant immunochemotherapy of murine neoplasms.
    Robinson JC; Gleiber W; Graff RJ
    Surg Forum; 1976; 27(62):147-50. PubMed ID: 1019835
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental study on local immunochemotherapy].
    Kasuga M; Sakita M; Yamane T; Torii T; Imai H; Kageyama N; Fujita Y; Majima S
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2113-21. PubMed ID: 6820889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental studies on specific active immunotherapy using immune responses of irradiated tumor tissue. 4. Effects of a combined use of a non-specific immunopotentiator, OK-432].
    Imanaka K; Ogawa Y; Gose K; Imajo Y; Kimura S
    Nihon Gan Chiryo Gakkai Shi; 1982 Aug; 17(5):1299-304. PubMed ID: 7153621
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental studies on specific active immunotherapy using immune response of irradiated tumor tissues. 5. A combined effect of the immune response of cryopreserved tissue and OK-432].
    Ogawa Y; Imanaka K; Gose K; Imajo Y; Kimura S
    Nihon Gan Chiryo Gakkai Shi; 1982 Aug; 17(5):1305-10. PubMed ID: 7153622
    [No Abstract]   [Full Text] [Related]  

  • 7. BCG-induced murine effector cells. I. Cytolytic activity in peritoneal exudates: an early response to BCG.
    Tracey DE; Wolfe SA; Durdik JM; Henney CS
    J Immunol; 1977 Sep; 119(3):1145-51. PubMed ID: 330748
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in resistance to tumor development in various strains of mice exposed to immunologic agents during the neonatal period].
    Volegov AI
    Biull Eksp Biol Med; 1981 Dec; 92(12):711-2. PubMed ID: 7326422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage function in tumor-bearing mice: tumoricidal and chemotactic responses of macrophages activated by infection with Mycobacterium bovis, strain BCG.
    Meltzer MS; Stevenson MM
    J Immunol; 1977 Jun; 118(6):2176-81. PubMed ID: 325142
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of immunopharmacologic treatment on anti-tumor immune response in lethally irradiated mice.
    Riccardi C; Santoni A; Puccetti P
    Boll Soc Ital Biol Sper; 1978 Aug; 54(15):1417-23. PubMed ID: 743444
    [No Abstract]   [Full Text] [Related]  

  • 11. Some characteristics of the cyclophosphamide-induced immunopotentiating cells in the spleen of mice bearing a large MOPC-315 tumor.
    Mokyr MB; Ye QW
    Cancer Res; 1985 Oct; 45(10):4932-9. PubMed ID: 4027979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCG immunotherapy: effects of dose and route of administration in mice bearing established tumors.
    Codish SD; Monaco AP
    Surg Forum; 1976; 27(62):150-2. PubMed ID: 1019836
    [No Abstract]   [Full Text] [Related]  

  • 13. [Characteristics in antitumor effects of organic silicon related compounds].
    Fukushima K
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2173-81. PubMed ID: 2544147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A review on mechanism of anti-tumor action of BCG (author's transl)].
    Tokunaga T
    Kekkaku; 1980 Aug; 55(8):351-7. PubMed ID: 6999202
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental and clinical trials with BCG immunotherapy.
    Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
    Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of BCG-activated macrophages on the B-16 melanoma.
    Papilian-Todoruţiu C; Rişcă R; Mulea R; Daicoviciu D
    Rom J Morphol Embryol; 1990; 36(2):129-34. PubMed ID: 2149421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclophosphamide-induced appearance of immunopotentiating T-cells in the spleens of mice bearing a large MOPC-315 tumor.
    Ye QW; Mokyr MB
    Cancer Res; 1984 Sep; 44(9):3873-9. PubMed ID: 6611201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of immunopotentiating agents (BCG, picibanil, and levamisole) and Maruyama vaccine on neutrophil functions including the generation of oxygen intermediates].
    Niwa Y; Maeda M
    Arerugi; 1983 Feb; 32(2):61-71. PubMed ID: 6615239
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-tumor effect of intratumoral administration of dendritic cells in combination with TS-1 and OK-432].
    Okamoto M; Ahmed SU; Oshikawa T; Tano T; Sato M
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1627-30. PubMed ID: 15553665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of Listeria factor Ei, BCG vaccine and a combination of both on the growth of experimental syngeneic tumors in inbred mice].
    Zák M; Mára M; Jirkovský J
    Sb Lek; 1989 Sep; 91(8-9):230-7. PubMed ID: 2562579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.